Abstract:Background & aims: Persistent activation of the inflammatory response contributes to the development of inflammatory bowel diseases, which increase the risk of colorectal cancer. We aimed to identify microRNAs that regulate inflammation during the development of ulcerative colitis (UC) and progression to colitis-associated colon cancer (CAC). Methods: We performed a quantitative polymerase chain reaction analysis to measure microRNAs in 401 colon specimens from patients with UC, Crohn's disease, irritable bowel syndrome, sporadic colorectal cancer, or CAC, as well as subjects without these disorders (controls); levels were correlated with clinical features and disease activity of patients. Colitis was induced in mice by administration of dextran sodium sulfate (DSS), and carcinogenesis was induced by addition of azoxymethane; some mice also were given an inhibitor of microRNA214 (miR214). Results: A high-throughput functional screen of the human microRNAome found that miR214 regulated the activity of nuclear factor-κB. Higher levels of miR214 were detected in colon tissues from patients with active UC or CAC than from patients with other disorders or controls and correlated with disease progression. Bioinformatic and genome-wide profile analyses showed that miR214 activates an inflammatory response and is amplified through a feedback loop circuit mediated by phosphatase and tensin homolog (PTEN) and PDZ and LIM domain 2 (PDLIM2). Interleukin-6 induced signal transducer and activator of transcription 3 (STAT3)-mediated transcription of miR214. A miR214 chemical inhibitor blocked this circuit and reduced the severity of DSS-induced colitis in mice, as well as the number and size of tumors that formed in mice given azoxymethane and DSS. In fresh colonic biopsy specimens from patients with active UC, the miR214 inhibitor reduced inflammation by increasing levels of PDLIM2 and PTEN. Conclusions: Interleukin-6 up-regulates STAT3-mediated transcription of miR214 in colon tissues, which reduces levels of PDLIM2 and PTEN, increases phosphorylation of AKT, and activates nuclear factor-κB. The activity of this circuit correlates with disease activity in patients with UC and progression to colorectal cancer.

MicroRNA‑449a is a Potential Predictor of Colitis‑associated Colorectal Cancer Progression.

Post-transcriptional Gene Regulation in Colitis Associated Cancer

Pro-inflammatory Cytokines Promote the Occurrence and Development of Colitis-associated Colorectal Cancer by Inhibiting Mir-615-5p.

MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice

Initial Study of Microrna Expression Profiles of Colonic Cancer Without Lymph Node Metastasis.

The Role of microRNAs in Development of Colitis-Associated Colorectal Cancer

MicroRNA-449a deficiency promotes colon carcinogenesis

Novel evidence for an oncogenic role of microRNA-21 in colitis-associated colorectal cancer

Dysregulation of miR-1-3p: An Early Event in Colitis-Associated Dysplasia

Circulating Mir-449A Predicts Survival Outcome for Colorectal Cancer Following Curative Resection: an Observational Study.

Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine

MicroRNA-144 Mediates Chronic Inflammation and Tumorigenesis in Colorectal Cancer Progression Via Regulating C-X-C Motif Chemokine Ligand 11

Autophagy Upregulates miR-449a Expression to Suppress Progression of Colorectal Cancer

Investigation of key miRNAs and their target genes in inflammatory bowel diseases and colitis-associated colorectal cancers using miRNA proifling and bioinformatic tools

TLR4 signaling in the development of colitis-associated cancer and its possible interplay with microRNA-155

A Combination of Microarray-Based Profiling and Biocomputational Analysis Identified miR331-3p and hsa-let-7d-5p as Potential Biomarkers of Ulcerative Colitis Progression to Colorectal Cancer

miRNA-Based Potential Biomarkers and New Molecular Insights in Ulcerative Colitis

Identification of CXCL10 and CXCL11 as the candidate genes involving the development of colitis-associated colorectal cancer

Increased miR-449a expression in colorectal carcinoma tissues is inversely correlated with serum carcinoembryonic antigen.

MicroRNAs As Biomarkers for the Progression and Prognosis of Colon Carcinoma.

MicroRNAs as biomarkers for colorectal cancer: recent advances